staphage lysate(redirected from Lincoln therapy)
Staphage LysateFringe pharmacology
A proprietary immunostimulant formulated by RE Lincoln, MD, which consists of the supernatant of Staphylococcus aureus that has been lysed by bacteriophages. Staphage Lysate evokes the production of interferons by activating macrophages; the lysate has no known effect in treating respiratory and sinus infections or cancer. While Staphage Lysate is an FDA-approved veterinary product, it is not approved for use in humans.
staphylococcus phage lysate; a preparation of Staphylococcus aureus and polyvalent staphylococcus bacteriophage used as an immunomodulator in the treatment of refractory pyodermas.